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Abstract
Background: Depression is underdiagnosed and undertreated in primary health care. When associated with chronic physical
disorders, it worsens outcomes. There is a clear gap in the treatment of depression in low- and middle-income countries
(LMICs), where specialists and funds are scarce. Interventions supported by m-health technologies might help to reduce this gap.
Mobile phones are widely used in LMICs offering potentially feasible and affordable alternatives for the management of
depression among individuals with chronic disorders.
Objective: To explore the potential effectiveness of a m-health intervention to help people with depressive symptoms and
comorbid hypertension and/or diabetes and to explore the feasibility of conducting large randomized controlled trials (RCTs).
Methods: Emotional Control (CONEMO) is a low-intensity psychoeducational 6-week intervention delivered via mobile phones
assisted by a nurse for reducing depressive symptoms among individuals with diabetes and/or hypertension. CONEMO was
tested in three pilot studies, one in São Paulo, Brazil, and two in Lima, Peru. Depressive symptoms were assessed using the
PHQ-9 at enrollment and at six-week follow up.
Results: The three pilot studies included a total of 66 people. Most participants were female between 41 and 60 years old. There
was a reduction in depressive symptoms as measured by PHQ-9 in all pilot studies. 38/66 participants reached treatment success
rate (PHQ9<10): 13 from São Paulo, 13 from first Lima pilot and 12 from second Lima pilot study. The intervention, the app and
the support offered by nurse and nurse assistants were well received by participants in both settings.
Conclusions: The intervention is feasible in both settings. Clinical data suggest that CONEMO might help to decrease
participants’ depressive symptoms. The findings also indicate that it is possible to conduct RCTs in these settings.
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
Page 3/34
JMIR Preprints Menezes et al
(JMIR Preprints 26/07/2018:11698) DOI: https://doi.org/10.2196/preprints.11698
Preprint Settings
1) Allow access to Preprints when not published (under review or accepted) for
(a) Open peer-review purposes.
(b) Logged-in Users only.
(c) Anybody, anytime.
(d) Nobody.
3) When a final version is published in a JMIR journal
(a) Allow download.
(b) Show abstract only.
4) Allow access to Preprints when no longer under consideration
(a) Logged-in Users only.
(b) Anybody, anytime.
(c) Nobody.
2) Accepted Setting
(a) Logged-in Users only.
(b) Anybody, anytime.
(c) Same as b), plus submit as ahead-of-print version to PubMed.
(d) Nobody.
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
Page 4/34
JMIR Preprints Menezes et al
Original Manuscript
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
Page 5/34
JMIR Preprints Menezes et al
Use of smartphone application to treat comorbidity depression with hypertension or diabetes I:
a pilot study in Brazil and Peru
Menezes, PR; Quayle, J; Claro, HG;  Silva, SA, Brandt, LR; Diez-Canseco, F;  Miranda, J; Price, L;
Mohr, D; Araya, R
Abstract
Background
Depression is underdiagnosed and undertreated in primary health care. When associated with chronic
physical disorders, it worsens outcomes. There is a clear gap in the treatment of depression in low-
and  middle-income  countries  (LMICs),  where  specialists  and  funds  are  scarce.  Interventions
supported by m-health technologies might help to reduce this gap. Mobile phones are widely used in
LMICs offering potentially feasible and affordable alternatives for the management of depression
among individuals with chronic disorders.
Objectives
To explore the potential  effectiveness of  a m-health intervention to help people with depressive
symptoms and comorbid hypertension and/or diabetes and to explore the feasibility of conducting
large randomized controlled trials (RCTs).
Methods
Emotional Control (CONEMO) is a low-intensity psychoeducational 6-week intervention delivered
via mobile phones assisted by a nurse for reducing depressive symptoms among individuals with
diabetes and/or hypertension. CONEMO was tested in three pilot studies, one in São Paulo, Brazil,
and two in Lima, Peru. Depressive symptoms were assessed using the Patient Health Questionnaire-9
(PHQ-9) at enrollment and at six-week follow up.  
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Results
The three pilot studies included a total of 66 people. Most participants were female between 41 and
60 years old.  There was a reduction in depressive symptoms as measured by PHQ-9 in all  pilot
studies. 38/66 (57.8%) participants reached treatment success rate (PHQ9<10): 13/21 (61.9%) from
São Paulo, 13/21 (61.9%) from first Lima pilot and 12/24 (50.0%) from second Lima pilot study. The
intervention, the app and the  support offered by nurse and nurse assistants  were well received by
participants in both settings. 
Conclusions
The intervention is  feasible  in  both settings.  Clinical data suggest that  CONEMO might  help to
decrease participants’ depressive symptoms. The findings also indicate that it is possible to conduct
RCTs in these settings. 
Keywords:  Depression, behavioral activation, m-health, pilot study, feasibility study, collaborative
care, task shifting, mobile intervention, PHQ-9. 
Introduction
Depression is a leading cause for the burden of disease worldwide, with 4.4% of the world’s
population suffering from depression {World, 2017, Depression and other common mental disorders:
global  health  estimates} [1,  2].  Depression is  associated with poverty,  low education  and social
exclusion,  all  of  them  more  common  in  low-  and  middle-income  countries   (LMICs)  [3-5].
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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Depression is also associated with physical chronic diseases and disability [3, 6]. The comorbidity of
depression  with  other  chronic  diseases  worsens  outcomes  in  physical  and  mental  conditions,
decreases quality of life and increases the economic burden [3, 7-10]. 
In LMICs, people with depression are commonly underdiagnosed and undertreated [5]. One
in every 27 people with depression receive treatment, and only 15% of these receive adequate care
[11]. There are marked staff shortages in LMIC, especially of the more specialized resources such as
psychiatrists,  psychologists  and psychiatric  nurses [5,  12].   Much of this  gap has to be covered
through the strategy of task shifting or transferring responsibilities for the care of the mentally ill to a
lower cadre of health workers [13]. However, task shifting also requires resources to identify, train,
and  supervise  non-specialized  health  care  workers  or  lay  counsellors,  which  is  frequently  not
available, making it difficult to scale it up in many environments. Digital mental health technologies,
which can provide treatment to patients via apps, and connect patients to a care coordinator, can
simplify care coordination tasks, reducing the amount of training, thereby providing a more scalable
process[14].  There is  a growing body of evidence that mobile  interventions for common mental
health  problems  such  as  depression  and  anxiety,  delivered  through  an  app  can  be  effective  in
reducing symptoms. Whether they are more effective when accompanied by support from a coach or
care coordinator than stand-alone solutions is still controversial [15]. 
The Latin America Treatment & Innovation Network in Mental Health (LATIN-MH) seeks to
develop and test a blended intervention for depression and comorbid chronic health problems, such
as hypertension and/or diabetes. We developed CONEMO (“Emotional Control”), a low-intensity
psychoeducational 6-week intervention delivered via mobile phones assisted by a nurse for reducing
depressive symptoms among individuals with diabetes and/or hypertension. 
The intervention aims to reduce depressive symptoms among patients with comorbid diabetes
and/or hypertension recruited in different health service units in São Paulo (Brazil) and Lima (Peru).
Therefore, the focus of this project is on providing patients tools through smartphones, with low-
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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intensity support that can be provided with minimal time by nurses or nurse assistants, who are
available in the clinics but have no specialized training in mental health. These professionals receive
specialized supervision provided by the study staff to perform their tasks. This intervention is unique
in LMICs in terms of using a technological platform and integrating the care of mental and physical
chronic conditions [16].
This pilot study aimed to: 
1) Explore the potential effectiveness and feasibility of using the CONEMO intervention to help
people with hypertension and/or diabetes and comorbid depressive symptoms;
2) Test recruitment strategies to estimate how many participants should be screened to reach our
target sample for fully powered Randomized Controlled Trials (RCTs); and
3) To assess acceptability and satisfaction of patients with the CONEMO intervention.
Methods
Study Design, Settings and Participants
We conducted three pilot studies during 2015-2016: one in São Paulo, Brazil,  and two in
Lima, Peru. São Paulo is the largest city of Brazil, with 11.2 million inhabitants [17]. Brazil offers
universal health coverage to its population with primary care playing a key role. The Family Health
Care Strategy (FHCS) aims to provide primary care close to where inhabitants live through family
health teams composed of one family or general physician, one nurse, two nurse assistants, and five
to six community health agents. [18]. Currently there are more than 43,000 Family Health Teams
covering 65%  of the total population in the country and 40% of the population in the city of São
Paulo[19]. A large survey estimated that approximately 10% of the population in Sao Paulo fulfilled
criteria  for  major  depression  in  the  past  12  months,  with  80%  presenting  moderate  to  severe
depression  [20].  A recent  census  indicated  that  Brazil  has  currently  5  psychiatrists  per  100,000
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
Page 9/34
JMIR Preprints Menezes et al
inhabitants, but the majority work only in the private sector.
Lima,  the capital  of Peru,  has approximately 9 million inhabitants,  one third of the total
Peruvian population[21]. The prevalence of depression has been estimated as 17,5% [22]. In Peru,
health care is offered both in public and private sectors, from primary to tertiary-care level,  and
although  the  current  mental  health  reform  is  aiming  at  shifting  mental  health  care  towards  a
community  approach,  the  majority  of  mental  health  care  is  still  restricted  to  tertiary-care  level
facilities [23]. The Peruvian health care system is administered by different entities: the Ministry of
Health (MINSA) (covering 60% of the population), EsSalud which is a social and health insurance
for employees (30% coverage), and armed forces, police and private sector (covering the remaining
10%) [24]. In Peru there are 0.6 psychiatrists per 100,000 inhabitants, well below the average for
LMICs.
In São Paulo we conducted the pilot study with four teams of two FHCS clinics. In Lima the
first pilot study took place in the endocrinology and cardiology outpatient consultation area of a
tertiary-level hospital from the MINSA, whilst in the second pilot patients were recruited in two
primary care health centers, mostly in the elderly adult consultation programs, where people with
NCDs are monitored, at EsSalud. Participants were eligible according to the following criteria: 
Inclusion criteria: 
1. Aged 21 or over; 
2. Hypertension and/or diabetes; 
2. Depressive symptoms, evaluated by the PHQ-9 (score ≥10);
3.  Self-reported reading ability in Portuguese (São Paulo) or Spanish (Lima);  
The exclusion criteria were: 
1. Psychosis symptoms detected by a 5-item screening questionnaire; 
2. Pregnancy (self-reported); 
3. High suicidal risk detected by a positive answer in the item 9 of the PHQ-9 followed by a
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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protocol to assess suicidal risk [Suicide Risk Assessment Protocol (S-RAP)];  and
4. Cognitive impairment detected by a 4-item questionnaire.
We  used  convenience  samples  in  the  three  pilot  studies.  We  envisaged  that  with  20
participants in each pilot we would be able to achieve the aims proposed. 
Measurements
We collected information about socioeconomic and demographic characteristics, depressive
symptoms, suicidal ideation, presence of psychosis symptoms, cognitive impairment, quality of life,
adherence to medical treatment, and disabilities (Table 1). 
Table 1: Description of instruments used in the pilot studies, time of application, and purpose. São
Paulo, Brazil, and Lima, Peru.
Instrument Time Purpose
First  Informed
Consent (S1)
Pre-Screening Introduction  of  the  study  and
obtaining consent for screening 
PHQ-2/PHQ9/S-
RAP (S2)
 Screening Assessment of depressive symptoms
and suicidal ideation
Second  Informed
Consent (B1)
Before baseline Consent to the study 
PHQ-9 Screening/Risk
Assessment  (1  and  3
weeks)/Follow up
Full  screening  for  depressive
symptoms
S-RAP Screening/Risk
Assessment  (1  and  3
weeks)/Follow up
Assess Suicidal Risk
PSQ Screening Assess the presence of psychosis
CSI-D Screening Evaluate cognitive impairment
Demographic and Baseline Information  about  participants
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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Socioeconomic
characteristics
socioeconomic  and  family
background 
Clinical data Baseline Medical history 
WHODAS-II Baseline/Follow-ups Assess functional disability
EQ-5D Baseline/Follow-ups Asses quality of life
Morisky
Medication
Adherence scale
Baseline/Follow-ups Evaluate  self-referred  medication
adherence
To explore the potential effectiveness of CONEMO intervention, we used the Patient Health
Questionnaire (PHQ-9) as the main measure of outcome [25]. We applied the PHQ-9 at baseline and
at the end of the 6-week intervention to assess severity of depressive symptoms. 
To  rule  out  the  presence  of  psychotic  symptoms  we  used  the  Psychosis  Screening
Questionnaire – PSQ [26], to assess cognitive impairment we used the Community Screening for
Dementia CSI-D [27], and to estimate quality of life the EuroQoL EQ-5D[28]). Among those taking
medication, we assessed adherence to medication treatment with the Morisky Medication adherence
scale  [29].  Disabilities  were assessed with the World Health Organization Disability  Assessment
Schedule - WHODAS-II[30]. 
We also used data from participants captured automatically by the CONEMO system in order
to monitor patients’ progress, including completion of sessions, intervals between accessing sessions,
or  sessions  missed.  We  collected  information  from  participants  about  the  acceptability  and
satisfaction with CONEMO app and the dashboard, through a questionnaire using a Likert scale of
five points at the end of the pilot study, where 1 is disagree and 5 is agree.
CONEMO Intervention  
We tested an intervention that could be delivered in existing general medical care settings by
available local personnel. The choice of a psychological intervention as the main component relates
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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to the public health need for these approaches in most LMICs. CONEMO is a smartphone-delivered
intervention,  supported  by  a  Nurse  Assistant  or  a  Nurse,  using  a  task-shifting  model,  as
recommended  by the  World  Health  Organization  [13,  31].  CONEMO consists  of  18  behavioral
activation sessions, delivered over six weeks (three sessions per week). As part of the behavioral
activation  program,  CONEMO aims  at  increasing  daily  life  activities,  especially  pleasant  ones,
healthy  ones  and  tasks,  as  well  as  providing  further  information  and health  self-care  messages,
increasing motivation and improving adherence to medication (Figure 1). Participants received a
device from the project with the CONEMO application installed, for use during the 6-week program,
returning it to the responsible nurse after that period. 
Figure 1: CONEMO app screenshots
The tasks of the nurse/NA were: 1) an initial contact by phone to schedule a training session
for the participant; 2) a face-to-face training session to introduce the CONEMO app; 3) a monitoring
call  after  week one  to  answer possible  queries  from participants  and to  reinforce  motivation  to
participate; 4) a monitoring call after week four with the same objectives as above; 5) a phone call to
schedule the closing meeting; 6) a final face-to-face appointment with the participant to finish the
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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intervention and return the smartphone. Nurses/NAs received weekly face-to-face supervision from
research clinical psychologists. 
Data analysis 
To test recruitment strategies, we analyzed data gathered during the process of recruiting and
enrolling participants (Aim 2).  The comparison of participants’ PHQ-9 scores at  baseline and at
follow-up allowed a preliminary assessment of potential effectiveness (Aim 1), and the number of
sessions completed and ratings on the satisfaction with the CONEMO intervention gave us an insight
into the acceptance of the CONEMO intervention (Aim 3).
The main outcome measure was patients’ PHQ-9 scores at the end of the 6-week intervention.
We considered  patients  had recovered when the  PHQ-9 score at  follow-up was <10.  Secondary
outcomes, such as disability levels, quality of life, and adherence to medication were also examined
at the end of the studies. Descriptive statistics were also used to assess participants’ perceptions at the
end of the study. We conducted all data analysis using STATA 11 [32].
Ethical Considerations
The pilot  studies were approved by local IRBs and the U.S. National Institute of Mental
Health (NIMH) Data and Safety Monitoring Board. Participants consented to participate in the study
and interviews took place after collecting the participants’ signatures on informed consent forms. All
investigators and research assistants involved in the data collection and analysis completed ethics
and human research good clinical practices training before starting their activities in the project.
Results
Assessment of recruitment strategy
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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We carried out one pilot study in São Paulo and two pilot studies in Lima. In São Paulo, four
nurses  from  the  two  participating  FHCS  clinics  were  responsible  to  support  the  CONEMO
intervention for participants recruited into the study. In the first pilot in Lima we employed a nurse to
support the delivery of the intervention, whereas in the second pilot study in Lima we worked with
six nurses employed by two public health care facilities. We included 66 patients in the three pilot
studies after approaching 793 people (Figure 2). Of 216 subjects approached in Sao Paulo, 21 (10%)
were included in the pilot study. In the two pilot studies in Lima we approached 577 subjects to
include 45 (8%) participants, 21 in the first and 24 in the second pilot studies. To recruit participants
we spent 30 days in the field in São Paulo, 21 days in Lima’s first pilot study and 24 in Lima’s
second pilot study. Most participants were women between 41-60 years old (Table 2). In São Paulo,
participants had lower educational level than in Lima.
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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 Figure  2:
Flow chart of recruitment and intervention in Lima and Sao Paulo
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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Table 2: Socioeconomic and demographic characteristics of participants included in the pilot studies
in São Paulo, Brazil and Lima, Peru.
  São Paulo 
n = 21 (%)
 Lima - pilot 1 
n = 21 (%)
 Lima - pilot 2
n = 24 (%)
Total
n=66 (%)
Age      
21-40 3 (14.3) 0 1 (4.2) 4 (6.1)
41-60 11 (52.4) 13 (61.9) 11 (45.8) 35 (53.0)
>=61 7 (33.3) 8 (38.1) 12 (50.0) 27 (40.9)
Gender     
Male 5 (23.8) 8 (38.1) 6 (25.0) 19 (28.8)
Female 16 (76.2) 13 (61.9) 18 (75.0) 47 (71.2)
Chronic disease     
HBP 14 (66.6) 1 (4.8) 9 (37.5) 24 (36.4)
DM 1 (4.8) 12 (57.1) 6 (25.0) 19 (28.8)
HBP + DM 6 (28.6) 8 (38.1) 9 (37.5) 23 (34.8)
Educational Level   
Primary School 12 (57.1) 3 (14.3) 4 (16.7) 19 (28.8)
High school 6 (28.6) 8 (38.1) 5 (20.8) 19 (28.8)
Technical course 3 (14.3) 4 (19.0) 7 (29.2) 14 (21.2)
University/Postgraduate 0 2 (9.5) 5 (20.8) 7 (10.6)
(missing   ) 0 4 (19.0) 3 (12.5) 7 (10.6)
Income (Brazilian Minimum Wage)     
0-4 minimum wage 14 (66.6)     14 (21.2)
more than 4 minimum wage 7 (33.3) 7 (10.6)
Income Peru (Soles)     
0 - 1500   9 (42.9) 7 (29.2) 16 (24.2)
More than 1500   7 (33.3) 12 (50.0) 19 (28.8)
Do not know / Did not answer 5 (23.8) 5 (20.8) 10 (15.2)
HBP: High Blood Pressure (Hypertension); DM: Diabetes Mellitus
Potential effectiveness and feasibility of CONEMO intervention
At the six-week follow up, there was 1 (4.8%) loss to follow-up in Sao Paulo, 6 (28.6%) in
the first and 8 (33.3%) in the second Lima pilot studies. Among participants who completed follow-
up assessments,  at  baseline 11 out of 20 (55.0%) had moderately severe or severe  symptoms of
depression in Sao Paulo (Figure 3). In Lima, none had severe symptoms at baseline and 8 out of 31
(25.8%) had moderately severe symptoms. At follow-up assessment, 13/20 (65.0%) participants had
recovered from depression (PHQ-9<10) in Sao Paulo, 13/15 (86.7%) in the first Lima pilot study and
12/16 (75.0%) in the second Lima pilot study (Figure 3). Only two (12.5%) participants in Lima’s
second pilot study worsened their level of depressive symptoms. Six participants (30%) presented
mild suicide risk at baseline in Sao Paulo, whereas in Lima none of the participants presented suicide
risk. In the follow-up assessments of the three pilot studies no participant presented suicide risk.
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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Figure 3: Severity of depressive symptoms at baseline and 6-week follow-up, according to PHQ-9
scores, for the three pilot studies (São Paulo, Brazil, and Lima, Peru). 
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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There was a trend for improvement in self-reported adherence to medical treatment in São
Paulo from baseline to 6-week follow-up (Table 3). No clear trends in adherence to medication were
noted in Lima. In São Paulo and Lima all participants presented some level of functional disability at
baseline, with more than 50% presenting moderate or severe functional disability. In all pilot studies,
there was a trend towards a reduction in levels of functional disability at the follow-up assessments
(Table 3). Regarding quality of life, we observed small inconsistent variations on EQ-5D scores from
baseline to 6-week follow-up (Table 3). 
Table 3: Medication adherence, functional disability, and quality of life during baseline and at 6-
week follow-up in São Paulo, Brazil and Lima, Peru. 
  São Paulo Lima - pilot 1 Lima – pilot 2
  (N=20 a) (N=15 a) (N=16 a)
  Baseline 6w - FUP Baseline 6w – FUP Baseline 6w - FUP
N  (%) N  (%) N  (%)
MORISKY
MEDICATION
ADHERENCE
SCALE
            
High adherence 
(0 points)
2 10
%
5 25% 2 13% 1 7% 7 44% 1 6%
Medium
adherence 
(1-2 points)
12 60
%
13 65% 8 53% 11 73% 6 38% 11 69%
Low adherence 
(3-4 points)
6 30
%
2 10% 5 33% 3 20% 3 19% 4 25%
WHODAS             
No Disability 0 0% 2 10% 0 0% 1 7% 0 0% 0 0%
Mild disability 9 45
%
10 50% 5 33% 9 60% 7 44% 9 56%
Moderate
disability
8 40
%
5 25% 7 47% 5 33% 7 44% 7 44%
Severe disability 3 15
%
3 15% 2 13% 0 0% 2 13% 0 0%
EQD-5             
Problems to walk 10 50 11 55% 10 67% 7 47% 7 44% 5 31%
https://preprints.jmir.org/preprint/11698 [unpublished, non-peer-reviewed preprint]
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%
Problems washing
or dressing
9 45
%
5 25% 3 20% 2 13% 1 6% 0 0%
Problems with
performing usual
activities
9 45
%
9 45% 8 53% 4 27% 5 31% 5 31%
Moderate or
extreme pain /
discomfort
14 70
%
16 80% 14 93% 11 73% 13 81% 11 69%
Moderate or
extreme anxiety /
depression
17 85
%
15 75% 7 47% 7 47% 12 75% 8 50%
a N = number of participants with follow up after 6 weeks. 
Access of participants to the CONEMO sessions decreased progressively overtime in the Sao
Paulo and in the 2nd Lima pilot study (Figure 4), whereas in the 1st Lima pilot study access started to
decrease only after 4 weeks of the intervention. Proportions of completion of sessions were 70% in
São Paulo, and 88% and 58% in the first and the second pilot studies in Lima, respectively. In São
Paulo, 87% of the participants accessed all first 6 sessions, whereas 95% and 76% did so in the 1 st
and 2nd pilot studies in Lima, respectively. Sixty-nine percent of participants in São Paulo, and 91%
and 50% in Lima accessed sessions 7 to 12. Adherence decreased for sessions 13 to 18, with 55% in
São Paulo, 80% and 48% in the 1st and 2nd studies in Lima, respectively. 
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Figure 4 – Proportion of participants who accessed each of the CONEMO app sessions in the
pilot studies in São Paulo, Brazil and Lima, Peru.
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The CONEMO app (participant interface) worked adequately during the trial, despite some
connectivity issues when receiving information on participants’ performance. These issues did not
affect the intervention or data collection. 
We collected data on acceptability and satisfaction with CONEMO from 20 participants in
São Paulo, 15 in Lima’s first pilot and 16 in Lima’s second pilot. The evaluation of the intervention
by participants  was  generally  positive:  all  mean ratings  were  above  3.5  points  (maximum of  5
points), both in São Paulo and Lima. Patients considered that the objectives were attained and that
the intervention helped their physical and mental health and to get organized. In their opinion the
duration of the intervention, the amount of contacts with the nurse/NA and the training received were
adequate (Table 4). 
Table 4: Evaluation of participants regarding CONEMO intervention in the pilot study in São Paulo,
Brazil and Lima, Peru. 
Intervention  aspects
evaluated
São Paulo
Average
grade
Lima 1
Average grade
Lima 2 
Average grade
Helped with physical health 4.1 4.0 3.8
Helped with mental health 4.4 4.4 4.3
Helped having the will to do things 3.9 4.3 4.3
Helped to get organized 3.6 4.3 4.3
Count on Nurse Assistant/nurse 4.5 4.1 4.1
Nurse Assistant/nurse helped 4.4 4.3 3.8
Number of contacts 4.1 3.6 3.2
Training quality 4.1 3.7 3.1
Intervention duration 4.1 2.8 2.9
Achievement of objectives 4.1 4.2 4.2
Satisfaction with results 4.3 4.4 4.3
Would indicate to a friend 3.6 4.6 4.5
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Participants considered the CONEMO app easy to use, were able to access videos and other
resources included in the app and thought the size of fonts and layout of the app was appropriate
(Table 5). They also assessed the role of nurses/NAs in the task shifting strategy proposed in the
CONEMO intervention.  They  considered  training,  procedures  and  availability  of  nurses/NAs  as
sufficient  or  good.  Around  90%  of  the  participants  in  all  pilots  considered  important  to  have
nurses/NAs support.
Table 5: Evaluation of participants regarding technological aspects of CONEMO app used during the
pilot studies in São Paulo, Brazil and Lima, Peru.
Item 
São Paulo 
Average grade
Lima  
Average grade
Lima 2 
Average
grade
Easy to use 4.4 4.3 3.8
Usefulness 4.6 4.7 4.4
Adequacy  of  frequency  of
sessions 
4.3 3.3 3.9
Content interesting 4.4 4.6 4.5
Video quality 4.4 4.6 4.4
Sound quality 3.9 4.6 4.3
Choices presented 4.1 4.6 4.5
Training session 4.3 4.0 4.3
Reminders 3.6 3.0 4.3
Discussion 
The  main  aim  of  the  present  pilot  study  was  to  explore  the  feasibility  and  potential
effectiveness of the CONEMO intervention for depressed people with co-morbid hypertension or
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diabetes. We also wanted to assess the feasibility of undertaking fully powered RCTs to test the
effectiveness of this intervention. We found that patients were able to use the CONEMO app, that
they  tended  to  show  improvement  in  the  severity  of  depressive  symptoms  by  the  end  of  the
intervention,  and that they were satisfied with the intervention.  Our results  are  encouraging and
suggest that the intervention is feasible and potentially effective with this population. 
In order to carry out RCTs we needed to ensure that we would be able to recruit participants
in the numbers needed. On average, out of each 13 participants screened we were able to include one
eligible participant in the study. In São Paulo and Lima recruitment took place in primary health care
units and additionally in the outpatient consultation areas of a public hospital in the first pilot study
in Lima, with patients presenting different conditions apart from hypertension and diabetes.  In both
sites, many participants were unable to read or write. As a result, it was necessary to pre-screen twice
as many patients than we first anticipated in order to reach the numbers we had planned for each
pilot study. This information allowed us to prepare a more realistic recruitment strategy and plan. 
The instruments and measures were well understood by participants, and research assistants
also provided positive feedback on their use. The outcome measures seemed sensitive to change and
allowed a useful characterization of the study sample. The research assistants did not refer problems
from the participants in understanding the instructions or questions included in the study. Since only
one  participant  showed  cognitive  impairment  and/or  psychotic  symptoms  in  the  screening,  the
assessment of these conditions may not be needed in the full trials. This will decrease the time taken
for screening interviews, also reducing costs for running the trials. 
Overall,  there  was  a  noticeable  trend  in  all  pilot  studies  for  a  reduction  on  depressive
symptoms over time, as measured by the PHQ-9. Our approach was categorical, using PHQ-9 cut-off
points to decide on caseness and severity. The proposed measure of clinical success, having a PHQ-9
score ≤9 at follow up (recovery), was considered a stringent but good measure. All our estimates,
though, need to be taken with caution as this pilot study was not powered to detect any statistically
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significant changes. 
Other  secondary  measures  of  success  of  the  intervention  also  yield  some  results  in  the
expected direction. Disability levels and medication adherence seemed to improve by the end of the
intervention. This trend was not as clear for the quality of life measure (EQ-5D).
The study also found that participants were satisfied with the intervention and the nurse/NA
support. Other studies have also shown benefits in the use of a collaborative care and task shifted
approaches in the treatment of depression [33-35]. Participants found the CONEMO app useful, easy
to use, and with interesting content. There was a decrease in adherence to the sessions over time,
which is consistent with a large majority of digital mental health interventions. This suggests a need
to review the content and organization of the sessions before the start of the RCTs. Changes should
include shortening sessions, making language simpler, and adding more video material. Reviewing
our strategy for persuasive design could also improve longer term adherence, such as including more
tailoring  and  personalization,  improving  the  quality  automated  notifications  (e.g.  positive
reinforcement for engagement), and leveraging contact with the nurse coordinator. We are hopeful
that these changes will improve session adherence in the  RCTs. 
Strengths and Limitations 
To the best of our knowledge, this is the first study that pilot tested a mobile intervention for
symptoms of depression among individuals with chronic conditions in two settings of middle-income
countries of Latin America. Our samples were small, so the pilot studies were not powered to test the
efficacy of the intervention, but our results were in the predicted direction, and the proportions of
treatment success in each sample are useful to calculate full trial sample sizes. We found that many
potentially eligible participants could not participate because of difficulties to read or write. This
could potentially affect the generalizability of the results. However, with the increasing literacy trend
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in younger generations in Latin America, these difficulties will decrease and more and more people
will be able to benefit from similar apps in the near future. 
Conclusions
The technological system CONEMO seems feasible to use in these settings with different
languages to help patients with diabetes or hypertension and co-morbid depressive symptoms. The
results from the three pilot studies are promising and support the implementation of fully powered
trials. CONEMO intervention will be one of the first evidence-based mobile interventions tested in
large samples in two different settings in LMICs. 
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Figure 3. Severity of depressive symptoms at baseline and 6-week follow-up, according to PHQ-9 scores, for the three pilot
studies (SÃ£o Paulo, Brazil, and Lima, Peru).
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